Evidence map›Paper›PMID 23271160›Full record

ArticleJournal of visualized experiments : JoVE2012

Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Jessica Morris, Patrick M Stuart, Megan Rogge, Chloe Potter, Nipun Gupta, Xiao-Tang Yin

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bolstering the Number and Function of HSV-1-Specific CD8Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  11. The evaluation of diagnostic efficiency for stromal herpes simplex keratitis by the combination of tear HSV-sIgA and HSV-DNA.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jessica MorrisDepartment of Ophthalmology, Saint Louis University.
Patrick M Stuart
Megan Rogge
Chloe Potter
Nipun Gupta
Xiao-Tang Yin
UCLouvain Saint-Louis Brussels · BESaint Louis University · US

Funding

AMELIORATION OF RECURRENT HERPES KERATITISR01EY011885 · NEI · WASHINGTON UNIVERSITY · PI STUART, PATRICK M · 1998 to 2007
$2.3M
Mechanisms of HSK ameliorationR01EY021247 · NEI · SAINT LOUIS UNIVERSITY · PI STUART, PATRICK M · 2011 to 2014
$1.4M
NEI NIH HHS EY11885NEI NIH HHS EY21247NEI NIH HHS R01 EY011885NEI NIH HHS R01 EY021247
6 · The paper itself

Abstract

Herpetic eye disease, termed herpetic stromal keratitis (HSK), is a potentially blinding infection of the cornea that results in over 300,000 clinical visits each year for treatment. Between 1 and 2 percent of those patients with clinical disease will experience loss of vision of the infected cornea. The vast majority of these cases are the result of reactivation of a latent infection by herpes simplex type I virus and not due to acute disease. Interestingly, the acute infection is the model most often used to study this disease. However, it was felt that a recurrent model of HSK would be more reflective of what occurs during clinical disease. The recurrent animal models for HSK have employed both rabbits and mice. The advantage of rabbits is that they experience reactivation from latency absent any known stimulus. That said, it is difficult to explore the role that many immunological factors play in recurrent HSK because the rabbit model does not have the immunological and genetic resources that the mouse has. We chose to use the mouse model for recurrent HSK because it has the advantage of there being many resources available and also we know when reactivation will occur because reactivation is induced by exposure to UV-B light. Thus far, this model has allowed those laboratories using it to define several immunological factors that are important to this disease. It has also allowed us to test both therapeutic and vaccine efficacy.

Indexed as

Disease Models, AnimalAnimalsChlorocebus aethiopsFemaleHerpes SimplexHerpesvirus 1, HumanHumansKeratitis, HerpeticMaleMiceMice, Inbred C57BLRecurrenceVero CellsVirus Activation

Identifiers

PMID23271160
PMCPMC3576418
OpenAlexW2022589835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.